San Diego, CA -- (SBWIRE) -- 10/15/2012 -- An investigation on behalf of investors of Edwards Lifesciences Corp (NYSE:EW) shares over potential securities laws violations by Edwards Lifesciences Corp and certain of its directors and officers in connection certain financial statements was announced.
Investors who purchased shares of Edwards Lifesciences Corp (NYSE:EW), have certain options and should contact the Shareholders Foundation at mail(at)shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Edwards Lifesciences Corp (NYSE:EW) concerning whether a series of statements by Edwards Lifesciences Corp regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Edwards Lifesciences Corp (NYSE:EW) reported that its annual Revenue rose from over $1.23 billion in 2008 to over $1.67 billion in 2011 and its Net Income rose from $128.90 million in 2008 to $236.70 million in 2011. Furthermore, Edwards Lifesciences said that its quarterly Revenue in 2012 rose from $459.20 million in the first quarter to $482.00 million in the second quarter and its quarterly Net Income rose from $65.10 million in the first quarter to $67.80 million in the second quarter.
Since its 2:1 split on May 28, 2010 shares of Edwards Lifesciences Corp (NYSE:EW) grew from as low as $52.46 in June 2010 to as high as $109.75 per share on October 4, 2012.
Then on October 8, 2012, Edwards Lifesciences Corp announced its preliminary third quarter 2012 sales. Edwards Lifesciences estimates total sales of $448 million for the third quarter that ended on September 30, 2012, which is lower than the Company's guidance of $465 million to $485 million provided during its second quarter earnings conference call on July 24, 2012.
Shares of Edwards Lifesciences Corp (NYSE:EW) dropped from $107.41 per share on October 8, 2012, to as low as $83.33 per share on October 10, 2012.
Those who purchased shares of Edwards Lifesciences Corp (NYSE:EW) and currently hold those Edwards Lifesciences Corp shares, may have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego